You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 37 No. 12, December 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Propranolol in Chronic Anxiety Disorders

A Controlled Study

Roger G. Kathol, MD; Russell Noyes, Jr, MD; Donald J. Slymen, MS; Raymond R. Crowe, MD; John Clancy, MD; Richard E. Kerber, MD

Arch Gen Psychiatry. 1980;37(12):1361-1365.


Abstract

• In a double-blind crossover study the β-adrenergic blocking drug propranolol hydrochloride reduced symptoms in 17 of 26 patients with chronic anxiety disorders. Both somatic and psychic symptoms improved as judged by patient and observer ratings. The most frequent side effects (dizziness, fatigue, and insomnia) were difficult to distinguish from anxiety symptoms and were, for the most part, mild. The therapeutic and side effects observed suggested CNS activity of the drug. Although propranolol is of benefit to patients with anxiety, its efficacy, compared with that of other antianxiety drugs, has not been established.



Author Affiliations

From the Departments of Psychiatry (Drs Kathol, Noyes, Crowe, and Clancy), Preventive Medicine and Environmental Health (Mr Slymen), and Internal Medicine (Drs Kerber and Kathol), University of Iowa, College of Medicine, Iowa City.


Footnotes

Accepted for publication July 25, 1980.

Reprint requests to Department of Psychiatry, University of Iowa, College of Medicine, 500 Newton Rd, Iowa City, IA 52242 (Dr Noyes).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Panic & Plaques: Panic Disorder & Coronary Artery Disease in Patients with Chest Pain
Katerndahl
J Am Board Fam Med 2004;17:114-126.
ABSTRACT | FULL TEXT  

Biphasic effects of propranolol on extinction of rewarded responding
Salmon
J Psychopharmacol 1989;3:83-87.
ABSTRACT  

Lactate Provocation of Panic Attacks: II. Biochemical and Physiological Findings
Liebowitz et al.
Arch Gen Psychiatry 1985;42:709-719.
ABSTRACT  

Social Phobia: Review of a Neglected Anxiety Disorder
Liebowitz et al.
Arch Gen Psychiatry 1985;42:729-736.
ABSTRACT  

A Benzodiazepine Receptor--Mediated Model of Anxiety: Studies in Nonhuman Primates and Clinical Implications
Insel et al.
Arch Gen Psychiatry 1984;41:741-750.
ABSTRACT  

Adrenergic Function in Patients With Panic Anxiety
Nesse et al.
Arch Gen Psychiatry 1984;41:771-776.
ABSTRACT  

The Anxiety Disorders
BROWN et al.
ANN INTERN MED 1984;100:558-564.
ABSTRACT  

Diazepam and Propranolol in Panic Disorder and Agoraphobia
Noyes et al.
Arch Gen Psychiatry 1984;41:287-292.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.